Hubert Walinski

Direktor/Vorstandsmitglied bei CIPHER PHARMACEUTICALS INC.

Vermögen: - $ am 30.04.2024

Health Technology

Consumer Services

Aktive Positionen von Hubert Walinski

Unternehmen	Position	Beginn	Ende
CIPHER PHARMACEUTICALS INC.	Direktor/Vorstandsmitglied	21.06.2023	-
CIPHER PHARMACEUTICALS INC.	Independent Dir/Board Member	21.06.2023	-
Aic Global Holdings, Inc.	Technik-/Wissenschafts-/F&E-Leiter	01.08.2021	-

Unternehmen	Position	Beginn	Ende
AstraZeneca Canada, Inc. AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2016	01.07.2021

University of British Columbia	Doctorate Degree
McMaster University	Undergraduate Degree

International

Kanada

Operativ

Chief Tech/Sci/R&D Officer	2
Director/Board Member	1
Independent Dir/Board Member	1

Sektoral

Health Technology	3
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
CIPHER PHARMACEUTICALS INC.	Health Technology

Private Unternehmen	2
Aic Global Holdings, Inc.
AstraZeneca Canada, Inc. AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada.	Health Technology

Private Unternehmen

Aic Global Holdings, Inc.

Health Technology